参考文献 (References)[1] A. K. F. Lo, K. W. Lo, S. W. Tsao, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia, 2006, 8(3): 173-180.
[2] K. W. Lo, K. F. To and D. P. Huang. Focus on nasopharyngeal carcinoma. Cancer Cell, 2004, 5(5): 423-428.
[3] W. T. Ng, C. W. Choi, M. C. Lee, et al. Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong. Fam Cancer. 2010, 9(2): 221-228.
[4] C. W. Choi, M. C. Lee, W. T. Ng, et al. An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models. Fam Cancer, 2011, 10(1): 133- 139.
[5] T. W. Wang, H. Y. Lu, P. J. Lou, et al. Application of highly sensitive, modified glass substrate-based immuno-PCR on the early detection of nasopharyngeal carcinoma. Biomaterials, 2008, 29(33): 4447-4454.
[6] D. K. Paramita, J. Fachiroh, S. M. Haryana, et al. Two-step Epstein-Barr virus immunoglobulin a enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma. Clinical and Vaccine Immunology, 2009, 16(5): 706-711.
[7] Y. Q. Tong, Z. J. Zhang, B. Liu, et al. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma. Proteomics, 2008, 8(15): 3185-3193.
[8] Y. S. Wei, Y. H. Zheng, W. B. Liang, et al. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer, 2008, 112(3): 544-551.
[9] X. W. Huang, W. Zhou, J. Chen, et al. A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2011, 46(6): 509-512.
[10] G. Henle, W. Henle. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer, 1976, 17(1): 1-7.
[11] S. M. Cao, Z. Liu, W. H. Jia, et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: A prospective screening study with a 20-year follow-up. PLoS One, 2011, 6(4): e19100.
[12] Y. Liu, Q. Huang, W. Liu, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: A two-stage design with a preliminary performance study and a Mass screening in southern china. International Journal of Cancer, 2011, Online Version of Record Published before Inclusion in an Issue.
[13] S.-Q. Jiang, Q. Liu. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Chinese Journal of Cancer, 2009, 28 (2): 177-180.
[14] 罗耀凌, 欧国萍, 池沛东等. 联合检测EB病毒相关抗体和抗原对诊断鼻咽癌的价值[J]. 癌症, 2009, 28(1): 96-99.
[15] H. Zheng, L. L. li, D. S. Hu, et al. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cellular & Molecular Immunology, 2007, 4(3): 185-196.
[16] S. P. Hao, N. M. Tsang and K. P. Chang. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer, 2003, 97(8): 1909-1913.
[17] S. P. Hao, N. M. Tsang, K. P. Chang, et al. Molecular diagnosis of nasopharyngeal carcinoma: detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngology Head Neck Surgery, 2004, 131(5): 651-654.
[18] J. H. Tong, R. K. Tsang, K. W. Lo, et al. Quantitative EpsteinBarr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal(NP) brushing samples from patients with NP carcinoma. Clinical Cancer Research, 2002, 8(8): 2612-2619.
[19] S. F. Leung, J. S. Tam, A. T. Chan, et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. Clinical Chemistry, 2004, 50(2): 339- 345.
[20] 张文玲, 周艳宏, 肖岚等. 鼻咽癌分子标志物研究[J]. 生物化学与生物物理进展, 2008, 35(1): 7-13.
[21] C. Maohuai, A. R. Chang and L. Shikyuen. Roles of DNA cytometry and detection of EBERs in predicting a diagnosis of nasopharyngeal carcinoma. Anal Quant Cytology Histology, 2002, 23(3): 207 -212.
[22] S. Q. Fan, J. Ma, J. Zhou, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Human Pathology, 2006, 37(5): 593-605.
[23] R. Dardari, W. Hinderer, D. Lang, et al. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: Complementary test of ZEBRA protein and early antigens p54 and p138. Journal of Clinical Microbiology, 2001, 39(9): 3164-3170.
[24] 汤敏中, 郑裕明, 蔡永林等. ZEBRA/IgG抗体检测在鼻咽癌血清学诊断中的应用[J]. 肿瘤防治研究, 2007, 34(5): 394.
[25] P. Feng, E. C. Ren, D. Liu, et al. Expression of EBV lytic gene BRLF1 in nasopharyngeal carcinoma:potential use in diagnosis. Journal of Genetic Virology, 2000, 81(10): 2417-2423.
[26] Y. Conolly, E. Littler, N. Sun, et al. Antibodies to Epstein-Barr virus thymidine kinase:a characteristic marker for the serological detection of nasopharyngeal carcinoma. International Journal of Cancer, 2001, 91(5): 692-697.
[27] S. H. Hutajulu, S. R. Indrasari, L. P. Indrawati, et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer, 2011, 10: 48.
[28] H. D. Zhou, G. Y. Li, Y. X. Yang, et al. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunology, 2006, 43(11): 1864- 1871.
[29] 倪海峰, 莫颖禧, 周晓莹等. P14ARF和p16 INK4a基因在鼻咽癌组织中异常甲基化及其临床意义[J]. 广西医科大学学报, 2008, 25(3): 341-343.
[30] 倪海峰, 黄光武, 张哲等. p27基因甲基化在鼻咽癌发生发展中的作用[J]. 解放军医学杂志, 2010, 35(2): 147-150.
[31] K. W. Lo, J. Kwong, A. B. Hui, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Research, 2001, 61(10): 3877-3881.
[32] J. Kwong, K. W. Lo, K. F. To, et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clinical Cancer Research, 2002, 8(1): 131-137.
[33] D. Sun, Z. Zhang, N. Van do, et al. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncology, 2007, 43(1): 82- 87.
[34] M. L. He, M. X. Luo, M. C. Lin, et al. MicroRNAs: Potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochemica et Biophysica Acta, 2011, 1825(1): 1-10.